These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1297917)

  • 41. Increased Resistance to Intradermal Francisella tularensis LVS Infection by Inactivation of the Sts Phosphatases.
    Parashar K; Kopping E; Frank D; Sampath V; Thanassi DG; Carpino N
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28630061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.
    Bosio CM; Elkins KL
    Infect Immun; 2001 Jan; 69(1):194-203. PubMed ID: 11119506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia.
    Havlasová J; Hernychová L; Brychta M; Hubálek M; Lenco J; Larsson P; Lundqvist M; Forsman M; Krocová Z; Stulík J; Macela A
    Proteomics; 2005 May; 5(8):2090-103. PubMed ID: 15892173
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
    Shen H; Chen W; Conlan JW
    Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ; Crane DD; Wehrly TD; Bosio CM
    Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
    Fulop M; Mastroeni P; Green M; Titball RW
    Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).
    Eyles JE; Hartley MG; Laws TR; Oyston PC; Griffin KF; Titball RW
    Microb Pathog; 2008 Feb; 44(2):164-8. PubMed ID: 17904793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis.
    Golovliov I; Ericsson M; Akerblom L; Sandström G; Tärnvik A; Sjöstedt A
    Vaccine; 1995 Feb; 13(3):261-7. PubMed ID: 7631511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.
    Rhinehart-Jones TR; Fortier AH; Elkins KL
    Infect Immun; 1994 Aug; 62(8):3129-37. PubMed ID: 8039881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expansion and retention of pulmonary CD4
    Roberts LM; Wehrly TD; Crane DD; Bosio CM
    Vaccine; 2017 May; 35(19):2575-2581. PubMed ID: 28372827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice.
    Quarry JE; Isherwood KE; Michell SL; Diaper H; Titball RW; Oyston PC
    Vaccine; 2007 Mar; 25(11):2011-8. PubMed ID: 17241711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain.
    Elkins KL; Bosio CM; Rhinehart-Jones TR
    Infect Immun; 1999 Nov; 67(11):6002-7. PubMed ID: 10531260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of genetic background on host resistance to experimental murine tularemia.
    Anthony LS; Skamene E; Kongshavn PA
    Infect Immun; 1988 Aug; 56(8):2089-93. PubMed ID: 3397185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonspecific early protective immunity in Francisella and Listeria infections can be dependent on lymphocytes.
    Elkins KL; MacIntyre AT; Rhinehart-Jones TR
    Infect Immun; 1998 Jul; 66(7):3467-9. PubMed ID: 9632626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mechanism of the changes in the animal reactivity to tularemia in mixed infection].
    Dunaeva TN; Ananova EV; Shlygina KN
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):57-61. PubMed ID: 415458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nlrp12 mutation causes C57BL/6J strain-specific defect in neutrophil recruitment.
    Ulland TK; Jain N; Hornick EE; Elliott EI; Clay GM; Sadler JJ; Mills KA; Janowski AM; Volk AP; Wang K; Legge KL; Gakhar L; Bourdi M; Ferguson PJ; Wilson ME; Cassel SL; Sutterwala FS
    Nat Commun; 2016 Oct; 7():13180. PubMed ID: 27779193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Route of Francisella tularensis infection informs spatiotemporal metabolic reprogramming and inflammation in mice.
    Jessop F; Schwarz B; Bohrnsen E; Bosio CM
    PLoS One; 2023; 18(10):e0293450. PubMed ID: 37883420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 60. Type I interferon licenses enhanced innate recognition and transcriptional responses to Franciscella tularensis live vaccine strain.
    Richard K; Vogel SN; Perkins DJ
    Innate Immun; 2016 Jul; 22(5):363-72. PubMed ID: 27231145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.